Evidence map›Paper›PMID 21941087›Full record

ArticleCell cycle (Georgetown, Tex.)2011

FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy.

Bulbul Pandit, Andrei L Gartel

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Trichostatin A potentiates TRAIL-induced antitumor effects via inhibition of ERK/FOXM1 pathway in gastric cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. FOX(M1) news--it is cancer.Molecular cancer therapeutics · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Bulbul PanditDepartment of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Andrei L Gartel
University of Illinois Chicago · US

Funding

The role of FoxM1 in pancreatic cancerR21CA134615 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GARTEL, ANDREI L · 2008 to 2009
$389k
NCI NIH HHS 1R01CA1294414NCI NIH HHS 1R21CA134615
6 · The paper itself

Abstract

Apoptosis has been widely accepted as the primary mechanism of drug-induced cell death. Recently, a second type of cell death pathway has been demonstrated: autophagy, also called programmed type II cell death. Autophagy is a highly regulated process, by which selected components of a cell are degraded. It primarily functions as a cell survival mechanism under stress. However, persistent stress can also promote extensive autophagy leading to cell death. Forkhead box M1 (FoxM1), an oncogenic transcription factor that is abundantly expressed in a wide range of human cancers. Here we evaluated the role of FoxM1 in sensitivity of human cancer cells to proteasome inhibitor-induced apoptosis and autophagy. We found that FoxM1 knockdown sensitized the human cancer cells to apoptotic cell death induced by proteasome inhibitors, such as, MG132, bortezomib and thiostrepton, while it did not affect the levels of autophagy following treatment with these drugs.

Indexed as

Proteasome InhibitorsApoptosisAutophagyBoronic AcidsBortezomibCaspase 3Cell Line, TumorForkhead Box Protein M1Forkhead Transcription FactorsHumansLeupeptinsProtease InhibitorsProteasome Endopeptidase ComplexPyrazinesRNA InterferenceRNA, Small Interferingbenzyloxycarbonylleucyl-leucyl-leucine aldehydeBoronic AcidsBortezomibCaspase 3Forkhead Box Protein M1Forkhead Transcription FactorsFOXM1 protein, humanLeupeptinsProtease InhibitorsProteasome Endopeptidase ComplexProteasome InhibitorsPyrazinesRNA, Small InterferingThiostrepton

Identifiers

PMID21941087
PMCPMC3233624
OpenAlexW1970126707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.